- Advances Endo's transformation into a leading global specialty healthcare company
- Establishes a platform for growth in key Latin American emerging markets
- Norbert Oppitz appointed Regional President, Latin America, Africa and Export Markets
Endo (ENDP) stock was trading sharply higher Friday morning after naming Paul Campanelli CEO.
The pharmaceutical company is reportedly up for sale after being dogged by Starboard Value for months, and could go for up to $41 million.
Endo (ENDP) stock was falling Friday afternoon after Hillary Clinton released a plan to combat skyrocketing drug prices.
Cutting down the 7 best S&P 500 stocks in August to a field of 2.